| Company Name | Curreio, Inc. |
| HQ Location | Room 357, South Clinical Research Laboratory, Tokyo University, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan, 113-8485 |
| Representative | CEO Motoki Nakai |
| Establishment | August 2019 |
| Capital | Approximately 400 million yen (including capital reserve) |
| Business Contents | Drug discovery and R & D business based on structural analysis using Cryo-EM |
| Legal Advisor | Anderson Mōri & Tomotsune |
| Shareholders | Beyond Next Ventures, T&D Innovation, Asahi Kasei Pharma Corporation, 3S Capital, U-Tokyo Entrepreneur Supporter’s Club, IKERUNippon Capital Partners, Ono Venture Investment, DOJIN CAPITAL, GEMSEKI, Etc. |